Linked Data API

Show Search Form

Search Results

1006995
star this property registered interest false more like this
star this property date less than 2018-11-14more like thismore than 2018-11-14
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading AAT Deficiency more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when he plans a NHS service for alpha-1 to improve patients' access to coordinated multi-disciplinary clinical expertise, which was approved by the Department's Prescribed Specialised Services Advisory Group in March 2016, to commence. more like this
star this property tabling member constituency Birkenhead more like this
star this property tabling member printed
Frank Field more like this
star this property uin 191307 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-11-21more like thismore than 2018-11-21
star this property answer text <p>The Specialised Respiratory Clinical Reference Group (CRG) is maintaining an oversight of the need to develop a service specification and selection of providers to offer specialised expertise and management advice for patients diagnosed with alpha1 antitrypsin deficiency (AATD).</p><p> </p><p>The CRG has recommended that NHS England wait until it is clear on the outcome of the National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies evaluation of human alpha1-proteinase inhibitor for treating emphysema in adults with documented severe AATD [ID856] until this development is taken forward.</p><p> </p><p>NICE has not yet published final guidance and recently consulted on its draft guidance. NICE’s evaluation committee is due to meet again to consider its recommendations in spring next year. This is to enable the company that makes the alpha1-proteinase inhibitor to prepare and submit additional information for consideration by the committee.</p> more like this
star this property answering member constituency Gosport remove filter
unstar this property answering member printed Caroline Dinenage more like this
star this property question first answered
remove filter
star this property answering member
4008
star this property label Biography information for Dame Caroline Dinenage more like this
star this property tabling member
478
unstar this property label Biography information for Lord Field of Birkenhead more like this